Tiotropium safety in 'real-world' populations

被引：2
|
作者：
Wise, Robert [1 ]
Anzueto, Antonio [2 ,3 ]
Dahl, Ronald [4 ]
Dusser, Daniel [5 ]
Calverley, Peter [6 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] Univ Texas San Antonio, San Antonio, TX USA
[3] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Odense Univ Hosp, Odense C, Denmark
[5] Univ Paris 05, Sorbonne Paris Cite, Hop Cochin, AP HP,Serv Pneumol, Paris, France
[6] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2016年 / 82卷 / 02期
关键词：
RESPIMAT; TRIAL;
D O I：
10.1111/bcp.12972
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：562 / 563
页数：2
相关论文
共 50 条
  • [1] Characterizing Real-World Use Of Tiotropium In Asthma In The USA
    Averell, Carlyne M.
    Laliberte, Francois
    Duh, Mei Sheng
    Wu, Jennifer W.
    Germain, Guillaume
    Faison, Sarai
    JOURNAL OF ASTHMA AND ALLERGY, 2019, 12 : 309 - 321
  • [2] Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations
    Horton, Daniel B.
    Blum, Michael D.
    Burcu, Mehmet
    JOURNAL OF PEDIATRICS, 2021, 238 : 312 - 316
  • [3] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [4] Real-world efficacy and safety of brolucizumab
    Walter, Scott
    Saba, Nicholas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [5] Real-world effectiveness and safety of alirocumab
    Mondelo Garcia, C.
    Garcia Queiruga, M.
    Balea Filgueiras, J.
    Fernandez Bargiela, N.
    Gimenez Arufe, V.
    Fernandez Oliveira, C.
    Martin Herranz, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 377 - 378
  • [6] Response to Wise et al. (Tiotropium safety in real life populations)
    Schmiedl, Sven
    Thuermann, Petra
    Fischer, Rainald
    Rottenkolber, Dominik
    Rottenkolber, Marietta
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (02) : 564 - 565
  • [7] Real-World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, C. C.
    Arca, K.
    Dunn, R.
    Girardo, M.
    Quillen, J.
    Dodick, D. W.
    Starling, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 96 - 96
  • [8] Real-world Experience with Ocrelizumab - A Safety Analysis
    Bolling, Jamie
    Vasquez, Matthew
    Sollero, Carlos Eduardo Vervloet
    Carlson, Aaron
    Gyang, Tirisham
    NEUROLOGY, 2020, 94 (15)
  • [9] Real-world efficacy, tolerability, and safety of ubrogepant
    Chiang, Chia-Chun
    Arca, Karissa N.
    Dunn, Rachel B.
    Girardo, Marlene E.
    Quillen, Jaxon K.
    Dodick, David W.
    Starling, Amaal J.
    HEADACHE, 2021, 61 (04): : 620 - 627
  • [10] Drug Safety and Relevant Issues in the Real-World
    Barbieri, Maria Antonietta
    Irrera, Natasha
    Convertino, Irma
    PHARMACEUTICALS, 2023, 16 (12)
12345